Free Trial
→ Rare signal predicts 50% market drop - before election (From Behind the Markets) (Ad) Free NRBO Stock Alerts

NeuroBo Pharmaceuticals (NRBO) Short Interest Ratio & Short Volume

$4.15
+0.06 (+1.47%)
(As of 07/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends

NeuroBo Pharmaceuticals Short Interest Data

Current Short Interest
52,700 shares
Previous Short Interest
92,600 shares
Change Vs. Previous Month
-43.09%
Dollar Volume Sold Short
$263,500.00
Short Interest Ratio
0.9 Days to Cover
Last Record Date
July 15, 2024
Outstanding Shares
4,910,000 shares
Float Size
325,300 shares
Short Percent of Float
16.20%
Today's Trading Volume
14,553 shares
Average Trading Volume
615,435 shares
Today's Volume Vs. Average
2%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling NeuroBo Pharmaceuticals ?

Sign up to receive the latest short interest report for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

NRBO Short Interest Over Time

NRBO Days to Cover Over Time

NRBO Percentage of Float Shorted Over Time

NeuroBo Pharmaceuticals Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202452,700 shares $263,500.00 -43.1%16.2%0.9 $5.00
6/30/202492,600 shares $448,184.00 +58.3%41.3%1.6 $4.84
6/15/202458,500 shares $222,885.00 -6.9%2.9%1.3 $3.81
5/31/202462,800 shares $239,268.00 +74.9%3.1%1.4 $3.81
5/15/202435,900 shares $152,216.00 -11.6%1.8%0.3 $4.24
4/30/202440,600 shares $133,980.00 -21.8%2.1%0.3 $3.30
4/15/202451,900 shares $183,207.00 -16.2%2.6%0 $3.53
3/31/202461,900 shares $253,171.00 -9.5%1.9%0 $4.09
3/15/202468,400 shares $314,640.00 +67.2%2.2%0.1 $4.60
2/29/202440,900 shares $236,811.00 -68.9%1.3%0 $5.79
2/15/2024131,700 shares $636,111.00 +395.1%4.1%0.1 $4.83
1/31/202426,600 shares $86,982.00 +39.3%0.8%0 $3.27
1/15/202419,100 shares $64,558.00 +180.9%0.4%0.6 $3.38
12/31/20236,800 shares $25,136.88 +15.3%0.2%0.2 $3.70
12/15/20235,900 shares $23,590.56 -90.1%0.2%0.5 $4.00
11/30/202359,600 shares $26,700.80 -31.8%N/A1 $0.45
11/15/202387,400 shares $37,599.48 -2.7%N/A1.3 $0.43
10/31/202389,800 shares $37,805.80 -29.5%N/A0.8 $0.42
10/15/2023127,400 shares $60,757.06 +4.3%N/A0.8 $0.48
9/30/2023122,200 shares $58,167.20 +11.1%N/A0.5 $0.48
9/15/2023110,000 shares $59,367.00 -20.1%N/A0.3 $0.54
8/31/2023137,700 shares $61,290.27 -48.0%0.8%0.4 $0.45
8/15/2023265,000 shares $163,770.00 +217.4%1.5%0.7 $0.62
7/31/202383,500 shares $42,835.50 -57.9%0.7%0.2 $0.51
7/15/2023198,500 shares $86,645.25 -67.5%1.5%0.5 $0.44
6/30/2023611,400 shares $267,242.94 +224.5%4.6%1.3 $0.44
6/15/2023188,400 shares $93,069.60 -20.6%1.4%0.5 $0.49
5/31/2023237,400 shares $132,944.00 -9.0%1.8%0.6 $0.56
5/15/2023261,000 shares $154,746.90 +15.6%2.0%0.5 $0.59
4/30/2023225,800 shares $144,512.00 +33.9%1.7%0.4 $0.64
4/15/2023168,600 shares $123,078.00 -26.5%2.3%0.2 $0.73
3/31/2023229,300 shares $162,871.79 -13.3%3.1%0.3 $0.71
3/15/2023264,500 shares $177,320.80 +28.1%4.2%0.2 $0.67
2/28/2023206,500 shares $132,160.00 -40.9%3.3%0.1 $0.64
2/15/2023349,400 shares $251,218.60 -46.1%5.6%0.1 $0.72
1/31/2023648,700 shares $512,473.00 +359.7%10.3%0.2 $0.79
1/15/2023141,100 shares $108,618.78 -85.3%2.2%0 $0.77
12/30/2022958,400 shares $687,652.00 -14.4%15.3%0.3 $0.72
12/15/20221,120,000 shares $1.69 million +29.4%N/A0.3 $1.51
11/30/2022865,400 shares $1.25 million -47.6%N/A0.3 $1.45
Nvidia insiders dumping shares (Ad)

All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.

To see Porter Stansberry's new AI prediction go here now.
11/15/20221,650,000 shares $2.34 million +837.0%45.1%0.6 $1.42
10/31/2022176,100 shares $1.35 million +257.2%9.2%0.1 $7.68
10/15/202249,300 shares $628,575.00 -46.8%9.6%0.1 $12.75
9/30/202292,600 shares $1.27 million -12.3%17.9%0.2 $13.69
9/15/2022105,600 shares $2.62 million -34.5%24.7%0.2 $24.82
8/31/2022161,300 shares $51,422.44 -7.5%1.3%0.1 $0.32
8/15/2022174,400 shares $71,172.64 -5.4%1.4%2 $0.41
7/31/2022184,300 shares $77,664.02 -17.7%1.4%1.9 $0.42
7/15/2022223,900 shares $125,406.39 +2.8%1.9%1.9 $0.56
6/30/2022217,900 shares $104,548.42 +17.2%1.9%1.7 $0.48
6/15/2022186,000 shares $74,772.00 -7.4%1.6%1.4 $0.40
5/31/2022200,900 shares $89,199.60 -15.8%1.7%1 $0.44
5/15/2022238,500 shares $121,444.20 -13.1%2.1%1.3 $0.51
4/30/2022274,400 shares $176,439.20 -8.8%2.4%1.5 $0.64
4/15/2022301,000 shares $261,659.30 -7.9%2.6%1.6 $0.87
3/31/2022326,900 shares $294,896.49 +31.6%2.9%1.6 $0.90
3/15/2022248,500 shares $191,842.00 +9.2%2.2%0.4 $0.77
2/28/2022227,500 shares $179,725.00 -6.0%2.0%0.4 $0.79
2/15/2022242,100 shares $225,153.00 -35.7%2.1%0.4 $0.93
1/31/2022376,500 shares $391,560.00 -9.5%3.3%0.6 $1.04
1/15/2022416,000 shares $544,960.00 +423.9%3.6%0.6 $1.31
12/31/202179,400 shares $96,868.00 +44.9%0.7%0.1 $1.22
12/15/202154,800 shares $76,720.00 -34.7%0.5%0.1 $1.40
11/30/202183,900 shares $135,079.00 +75.5%0.7%0.2 $1.61
11/15/202147,800 shares $87,474.00 -53.9%0.4%0.1 $1.83
10/29/2021103,600 shares $183,372.00 -77.5%1.1%0.2 $1.77
10/15/2021460,600 shares $875,140.00 +340.8%4.9%0.8 $1.90
9/30/2021104,500 shares $388,740.00 -11.1%1.1%0 $3.72
9/15/2021117,600 shares $453,936.00 -18.8%1.5%0.1 $3.86
8/31/2021144,800 shares $599,472.00 -40.8%1.8%0.1 $4.14
8/13/2021244,500 shares $865,530.00 -43.0%3.1%0.1 $3.54
7/30/2021429,200 shares $1.41 million +122.4%5.4%0.2 $3.29
7/15/2021193,000 shares $528,820.00 -14.8%2.5%0.1 $2.74
6/30/2021226,400 shares $753,912.00 -52.8%2.9%0.9 $3.33
6/15/2021479,300 shares $1.60 million +18.8%6.2%1.9 $3.34
5/28/2021403,400 shares $1.14 million +7.1%5.3%3.3 $2.82
5/14/2021376,600 shares $1.04 million +4.8%4.9%2.6 $2.77
4/30/2021359,300 shares $1.28 million +4.3%4.7%1.7 $3.56
4/15/2021344,500 shares $1.30 million +8.4%4.5%0.9 $3.76
3/31/2021317,800 shares $1.35 million +143.3%4.2%0.8 $4.26
3/15/2021130,600 shares $578,558.00 -6.6%1.7%0.3 $4.43
2/26/2021139,800 shares $648,672.00 -42.1%1.6%0.4 $4.64
2/12/2021241,500 shares $1.34 million -73.3%2.7%0.7 $5.53
1/29/2021902,900 shares $5.16 million +545.4%14.3%2.9 $5.72
1/15/2021139,900 shares $864,582.00 +2.6%2.2%1.3 $6.18
12/31/2020136,400 shares $754,292.00 +11.7%2.9%2.2 $5.53
12/15/2020122,100 shares $667,887.00 -3.3%2.2%6.9 $5.47
11/30/2020126,300 shares $684,546.00 -0.8%2.3%8 $5.42
11/15/2020127,300 shares $669,598.00 +1.9%2.3%7.4 $5.26
10/30/2020124,900 shares $666,966.00 -5.5%2.2%6.8 $5.34
Nvidia insiders dumping shares (Ad)

All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.

To see Porter Stansberry's new AI prediction go here now.
10/15/2020132,200 shares $831,538.00 -1.9%2.4%4.6 $6.29
9/30/2020134,800 shares $757,576.00 +7.8%2.4%3.2 $5.62
9/15/2020125,100 shares $783,126.00 -17.0%2.2%1.9 $6.26
8/31/2020150,700 shares $916,256.00 -11.4%2.7%2.1 $6.08
8/14/2020170,100 shares $1.12 million -16.0%3.1%2.3 $6.57
7/31/2020202,500 shares $1.30 million -34.7%3.7%2.9 $6.41
7/15/2020309,900 shares $2.38 million +54.3%5.6%5 $7.69
6/30/2020200,800 shares $1.67 million +184.0%3.6%3.6 $8.31
6/15/202070,700 shares $671,650.00 +12.0%1.3%2.3 $9.50
5/29/202063,100 shares $831,027.00 +3.6%1.1%2.7 $13.17
5/15/202060,900 shares $801,444.00 +407.5%1.1%2.7 $13.16
4/30/202012,000 shares $170,520.00 +100.0%0.2%0.4 $14.21
4/15/20206,000 shares $100,200.00 -18.9%0.1%0.2 $16.70
3/31/20207,400 shares $110,482.00 -28.2%0.1%0.3 $14.93
3/13/202010,300 shares $297,258.00 -64.0%0.2%0.6 $28.86
2/28/202028,600 shares $256,542.00 -8.6%0.5%1.1 $8.97
2/14/202031,300 shares $453,850.00 +69.2%0.5%1.3 $14.50
1/31/202018,500 shares $315,055.00 +110.2%0.2%1.6 $17.03
1/15/20208,800 shares $129,360.00 -17.8%0.1%1.3 $14.70
12/31/201910,700 shares $87,847.00 No Change0.3%1.9 $8.21

NRBO Short Interest - Frequently Asked Questions

What is NeuroBo Pharmaceuticals' current short interest?

Short interest is the volume of NeuroBo Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 52,700 shares of NRBO short. 16.20% of NeuroBo Pharmaceuticals' shares are currently sold short. Learn More on NeuroBo Pharmaceuticals' current short interest.

What is a good short interest ratio for NeuroBo Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NRBO shares currently have a short interest ratio of 1.0. Learn More on NeuroBo Pharmaceuticals's short interest ratio.

What is a good short interest percentage for NeuroBo Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.20% of NeuroBo Pharmaceuticals' floating shares are currently sold short.

Is NeuroBo Pharmaceuticals' short interest increasing or decreasing?

NeuroBo Pharmaceuticals saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 52,700 shares, a decrease of 43.1% from the previous total of 92,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is NeuroBo Pharmaceuticals' float size?

NeuroBo Pharmaceuticals currently has issued a total of 4,910,000 shares. Some of NeuroBo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroBo Pharmaceuticals currently has a public float of 325,300 shares.

How does NeuroBo Pharmaceuticals' short interest compare to its competitors?

16.20% of NeuroBo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to NeuroBo Pharmaceuticals: Benitec Biopharma Inc. (3.73%), SCYNEXIS, Inc. (2.91%), LifeVantage Co. (0.79%), Assembly Biosciences, Inc. (0.33%), PMV Pharmaceuticals, Inc. (2.66%), BeyondSpring Inc. (9.34%), Kronos Bio, Inc. (2.04%), Marinus Pharmaceuticals, Inc. (4.92%), Chimerix, Inc. (2.00%), Milestone Pharmaceuticals Inc. (0.74%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

What does it mean to sell short NeuroBo Pharmaceuticals stock?

Short selling NRBO is an investing strategy that aims to generate trading profit from NeuroBo Pharmaceuticals as its price is falling. NRBO shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against NeuroBo Pharmaceuticals?

A short squeeze for NeuroBo Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRBO, which in turn drives the price of the stock up even further.

How often is NeuroBo Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRBO, twice per month. The most recent reporting period available is July, 15 2024.



Related Companies:
Short Interest Tools:
This page (NASDAQ:NRBO) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...
Crypto Swap Profits | Sponsored
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...
Unstoppable Prosperity | Sponsored
This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...
Monument Traders Alliance | Sponsored
Collapse of the Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...
Colonial Metals | Sponsored
Rare signal predicts 50% market drop - before election
The market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...
Behind the Markets | Sponsored
Must-See: Elon’s New Invention is Absolutely Insane
Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...
InvestorPlace | Sponsored
Elon to Transform U.S. Economy?
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...
Porter & Company | Sponsored
5 Stocks that could triple in a week
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...
Traders Agency | Sponsored